日本TAVR注册研究中死亡率预测模型的外部验证
本研究在日本多中心TAVI注册中验证5个短期(30天)和3个长期(1年)死亡率预测模型。短期模型中NHR和STS-PRoM区分度最高但均高估风险,经截距重校准后改善;长期模型中OCEAN-TAVI和Osaka大学模型区分度最高,OCEAN-TAVI校准最佳。
要点
- 日本TAVR患者中短期死亡率1.4%,长期死亡率14.5%。
- 短期预测模型NHR(AU-ROC 0.82)和STS-PRoM(0.78)区分度最佳。
- 长期预测模型OCEAN-TAVI和Osaka大学模型AU-ROC均为0.75,OCEAN-TAVI校准最好。
核心结论
- 在日本TAVR患者中,经重校准后STS-PRoM和NHR模型短期表现更优,OCEAN-TAVI长期整体表现最佳。
研究设计与样本
- 基于日本KPUM TAVI前瞻性多中心注册,分析2016至2023年行TAVR的患者。
- 短期死亡率分析纳入1756例,长期死亡率分析纳入1235例。
- 验证5个短期(30天)和3个长期(1年)死亡率预测模型,评估区分度与校准。
主要发现
- 短期死亡风险1.4%(n=25),长期死亡风险14.5%(n=179)。
- 短期模型中NHR的AU-ROC为0.82,STS-PRoM为0.78,所有模型均高估风险,截距重校准后改善。
- 长期模型中OCEAN-TAVI和Osaka大学模型的AU-ROC均为0.75,OCEAN-TAVI校准最佳。
临床怎么用
- 在日本TAVR患者风险分层中,短期可优先考虑经重校准的STS-PRoM或NHR模型。
- 长期风险预测可优先使用OCEAN-TAVI模型,其校准性能最佳。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Mortality prediction models (MPMs) play a crucial role in risk assessment for transcatheter aortic valve replacement (TAVR), but their external validity in Japanese patients remains unclear. This study evaluated the performance of existing short-term (30-day) and long-term (1-year) MPMs with Japanese TAVR patients. METHODS: We analysed patients who underwent TAVR between 2016 and 2023 in the KPUM transcatheter aortic valve implantation (TAVI) registry, a prospective multicentre registry in Japan. Five short-term (30-day) MPMs (Society of Thoracic Surgeons Predicted Risk of Mortality [STS-PRoM], French Aortic National CoreValve and Edwards registry [FRANCE-2], Observational Study Of Appropriateness, Efficacy And Effectiveness of AVR-TAVR Procedures For the Treatment Of Severe Symptomatic Aortic Stenosis registry [OBSERVANT], American College of Cardiology-TAVI [ACC-TAVI], and Netherlands Heart Registration [NHR] models) and 3 long-term (1-year) MPMs (Optimized CathEter vAlvular iNtervention-TAVI [OCEAN-TAVI], Osaka University, and TAVR-Risk [TARI] models) were validated. Model performance was assessed using the area under the receiver operating characteristic curve (AU-ROC) for discrimination and calibration plots/slope/intercept for calibration. Intercept recalibration was performed for short-term MPMs. RESULTS: Among 1756 patients analysed for short-term mortality, the mortality risk was 1.4% (n = 25), while among 1235 patients analysed for long-term mortality, the mortality risk was 14.5% (n = 179), respectively. Among short-term MPMs, NHR (AU-ROC: 0.82) and STS-PRoM (0.78) showed the highest discrimination, though all models overestimated mortality risk, which improved after intercept recalibration. Among long-term MPMs, the OCEAN-TAVI and Osaka University models (AU-ROC: 0.75) showed the highest discrimination, with the OCEAN-TAVI demonstrating the best calibration. CONCLUSIONS: In Japanese TAVR patients, STS-PRoM and NHR models showed superior short-term performance after recalibration, while OCEAN-TAVI demonstrated the best overall long-term performance. Future research should explore machine learning-based models to improve risk prediction accuracy and clinical applicability.
引用
- Shibata R, Seki T, Takeda Y, et al. External Validation of Mortality Prediction Models in Japanese Transcatheter Aortic Valve Replacement Registry. Eur J Cardiothorac Surg. 2025. PMID: 40632610. doi:10.1093/ejcts/ezaf227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。